This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Finance & Accounting for Bioscience
September 16-17, 2025
Sheraton BostonBoston, MA

Kyle Breidenstine
Vice President, Finance & Controller at PepGen
Speaker

Profile


Kyle Breidenstine is the Vice President of Finance and Controller at PepGen Inc. Kyle has extensive experience supporting venture-backed biotech startups. He played a pivotal role in PepGen’s initial public offering and led the finance team through its transition to a public company, including building out the accounting, reporting, and FP&A functions.

Before joining PepGen, Kyle held progressively senior roles in the finance team at Orchard Therapeutics, where he was a key contributor to the company’s IPO and several successful equity offerings. Earlier in his career, he worked at PwC, working with both public and private clients in the biotech and healthcare sectors. He began his finance career as a budget analyst for the Commonwealth of Massachusetts.

Kyle is a licensed CPA in Massachusetts. He holds an MBA from the D’Amore-McKim School of Business at Northeastern University and a BA in Political Science from Clark University.

Agenda Sessions

  • Maximizing Runway: Smart Cash Management Strategies for Biotech

    3:15pm